92
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on IL17, RORγt, IL4 and GATA3 gene expressions in rheumatoid arthritis patients

, , , &
Pages 1027-1033 | Published online: 30 Mar 2017

References

  • LeeKYMooneyDJAlginate: properties and biomedical applicationsProg Polym Sci2012371 106 12622125349
  • TønnesenHHKarlsenJAlginate in drug delivery systemsDrug Dev Ind Pharm2002286 621 63012149954
  • SavarinoEPohlDZentilinPFunctional heartburn has more in common with functional dyspepsia than with non-erosive reflux diseaseGut2009589 1185 119119460766
  • MirshafieyARehmBHAlginate and its comonomer mannuronic acid: medical relevance as drugsRehmBHAlginates: Biology and ApplicationsBerlin HeidelbergSpringer2009 229 260
  • MirshafieyARehmBAbhariRSBorzooyZSotoudeMRazaviAProduction of M2000 (β-d-mannuronic acid) and its therapeutic effect on experimental nephritisEnviron Toxicol Pharmacol2007241 60 6621783790
  • MirshafieyARehmBSotoudeMRazaviAAbhariRSBorzooyZTherapeutic approach by a novel designed anti-inflammatory drug, M2000, in experimental immune complex glomerulonephritisImmunopharmacol Immunotoxicol2007291 49 6117464766
  • MirshafieyACuzzocreaSRehmBMatsuoHM2000: a revolution in pharmacologyMed Sci Monit2005118 I53 I63
  • MirshafieyAMatsuoHNakaneSRehmBHKohCSMiyoshiSNovel immunosuppressive therapy by M2000 in experimental multiple sclerosisImmunopharmacol Immunotoxicol2005272 255 26516114509
  • MirshafieyACuzzocreaSRehmBMazzonESaadatFSotoudeMTreatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drugScand J Immunol2005615 435 44115882435
  • MirshafieyAKhorramizadehMRSaadatFRehmBHAChemo-preventive effect of M2000, a new anti-inflammatory agentMed Sci Monit20041010 I105 I109
  • FattahiMJAbdollahiMAgha MohammadiAPreclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drugImmunopharmacol Immunotoxicol2015376 535 54026584020
  • ArnettFCEdworthySMBlochDAThe American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritisArthritis Rheum1988313 315 3243358796
  • CopeASchulze-KoopsHAringerMThe central role of T cells in rheumatoid arthritisClin Exp Rheumatol2007255 S417977483
  • SarkarSCooneyLFoxDAThe role of T helper type 17 cells in inflammatory arthritisClin Exp Rheumatol20101593 225 237
  • OhmuraKNguyenLTLocksleyRMMathisDBenoistCInterleukin-4 can be a key positive regulator of inflammatory arthritisArthritis Rheum2005526 1866 187515934072
  • GaffenSLThe role of interleukin-17 in the pathogenesis of rheumatoid arthritisCurr Rheumatol Rep2009115 365 37019772832
  • SinghJAFurstDEBharatA2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisArthritis Care Res (Hoboken)2012645 625 63922473917
  • GøtzschePCJohansenHKShort-term low-dose corticosteroids vs placebo and nonsteroidal anti-inflammatory drugs in rheumatoid arthritisCochrane Library2005 1
  • LaineLBombardierCHawkeyCJStratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritisGastroenterology20021234 1006 101212360461
  • BinghamCOThe pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammationJ Rheumatol200265 3 9
  • RicciottiEFitzGeraldGAProstaglandins and inflammationArterioscler Thromb Vasc Biol2011315 986 100021508345
  • McInnesIBSchettGCytokines in the pathogenesis of rheumatoid arthritisNat Rev Immunol200776 429 44217525752
  • McInnesIBSchettGThe pathogenesis of rheumatoid arthritisN Engl J Med201136523 2205 221922150039
  • McKenzieGJFallonPGEmsonCLGrencisRKMcKenzieANSimultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2–mediated responsesJ Exp Med199918910 1565 157210330435
  • TesmerLALundySKSarkarSFoxDATh17 cells in human diseaseImmunol Rev20082231 87 11318613831
  • MiossecPIL-17 and Th17 cells in human inflammatory diseasesMicrobes Infect2009115 625 63019371791
  • Al-SaadanyHMHusseinMSGaberRAZaytounHATh-17 cells and serum IL-17 in rheumatoid arthritis patients: correlation with disease activity and severityEgypt Rheumatol2016381 1 7
  • KoshyPHendersonNLoganCLifePFCawstonTERowanADInterleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokinesAnn Rheum Dis2002618 704 71312117676
  • PetersTLMcClainKLAllenCENeither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesionsMol Ther2011198 1433 143921654633
  • RatajewskiMWalczak-DrzewieckaASałkowskaADastychJUpstream stimulating factors regulate the expression of RORγT in human lymphocytesJ Immunol20121896 3034 304222891280
  • KehrmannJTaturaRZeschnigkMImpact of 5-aza-2′-deoxycytidine and epigallocatechin-3-gallate for induction of human regulatory T cellsJ Immunol20141423 384 395
  • ChiuYHChenHGATA3 inhibits GCM1 activity and trophoblast cell invasionSci Rep20166 2163026899996
  • NathanCDingANonresolving inflammationCell20101406 871 88220303877
  • SinghJAChristensenRWellsGABiologics for rheumatoid arthritis: an overview of Cochrane reviewsSao Paulo Med J20101285 309 31021181074
  • LeeYHRhoYHChoiSJJiJDSongGGAssociation of TNF-alpha–308 G/A polymorphism with responsiveness to TNF-α-blockers in rheumatoid arthritis: a meta-analysisRheumatol Int2006272 157 16116909270
  • DayRAdverse reactions to TNF-α inhibitors in rheumatoid arthritisLancet20023599306 540 54111867103